REQUEST A DEMO
Total
USD $0.00
Search more companies

Sanofi Romania SRL (Romania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sanofi Romania SRL Profile Updated: July 01, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English Download a sample report

Sanofi-Aventis Romania SRL is engaged in the research, development, manufacturing and marketing of innovative therapeutic solutions. Sanofi-Aventis Romania SRL has core strengths in healthcare, with 7 growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme.

Headquarters
Strada Gara Herastrau Nr. 4
Bucharest; Bucharest; Postal Code: 020334

Contact Details: Purchase the Sanofi Romania SRL report to view the information.

Website: http://www.sanofi.ro

Basic Information
Total Employees:
Purchase the Sanofi Romania SRL report to view the information.
Outstanding Shares:
Purchase the Sanofi Romania SRL report to view the information.
Registered Capital:
Purchase the Sanofi Romania SRL report to view the information.
Financial Auditors:
Purchase the Sanofi Romania SRL report to view the information.
Ratings:
Purchase the Sanofi Romania SRL report to view the information.
Incorporation Date:
October 28, 1998
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Opella Healthcare Romania SRL
100%
Company Performance
Financial values in the chart are available after Sanofi Romania SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
18.96%
Total operating revenue
18.96%
Operating profit (EBIT)
110.1%
EBITDA
102.68%
Net Profit (Loss) for the Period
110.8%
Total assets
-3.95%
Total equity
46.27%
Operating Profit Margin (ROS)
4.55%
Net Profit Margin
4.05%
Return on Equity (ROE)
9.68%
Quick Ratio
0.27%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?